Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Shanghai researchers have devised a revolutionary, non-invasive method to monitor blood glucose, allowing for accurate blood ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...

A three-year, $1.4m project aims to address inequities experienced by Māori and Pacific people with type 1 diabetes.

According to a new market research report titled ' Network Monitoring Market by Offering (Equipment, Software, Services), ...

REDDING, Calif., Jan. 30, 2025 /PRNewswire/ -- According to a new market research report titled ' Network Monitoring Market by Offering (Equipment, Software, Services), Technology (Ethernet, Fiber ...